Ipilimumab induced digital vasculitis.

about

Ipilimumab induced digital vasculitis.

Item

http://www.wikidata.org/entity/Q50057704

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Ipilimumab induced digital vasculitis.

@en

Ipilimumab induced digital vasculitis.

@nl

type

Item

label

Ipilimumab induced digital vasculitis.

@en

Ipilimumab induced digital vasculitis.

@nl

prefLabel

Ipilimumab induced digital vasculitis.

@en

Ipilimumab induced digital vasculitis.

@nl

P1476

Ipilimumab induced digital vasculitis.

@en

P2093

Ajjai Alva

http://www.w3.org/2001/XMLSchema#string

Elena Schiopu

http://www.w3.org/2001/XMLSchema#string

Justin Sovich

http://www.w3.org/2001/XMLSchema#string

Leslie Fecher

http://www.w3.org/2001/XMLSchema#string

Vincent Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial

Ipilimumab and its toxicities: a multidisciplinary approach

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study.

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.

Immunostimulatory monoclonal antibodies for cancer therapy.

Ipilimumab: controversies in its development, utility and autoimmune adverse events.

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.

Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents.

P2888

s40425-018-0321-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/S40425-018-0321-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amrita Padda

P577

2018-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100989667

http://www.w3.org/2001/XMLSchema#string

P698

29433584

http://www.w3.org/2001/XMLSchema#string

P932

5809839

http://www.w3.org/2001/XMLSchema#string